What Researchers Did
A team of researchers described the case of a 35-year-old woman with systemic lupus erythematosus (SLE) who developed a rare bowel condition called pneumatosis cystoides intestinalis (PCI) after experiencing lupus-related inflammation of her intestines and abdomen.
What They Found
The patient initially improved from lupus enteritis and peritonitis with prednisolone, but then developed PCI six weeks later. Her PCI successfully improved after receiving a combination of treatments, including reduced prednisolone, other medications, bowel rest, intravenous nutrition, and hyperbaric oxygen therapy. This case suggests that lupus enteritis might increase the risk for PCI, and high doses of prednisolone could worsen it.
What This Means for Canadian Patients
For Canadian patients with systemic lupus erythematosus, this case highlights a rare but serious complication called pneumatosis cystoides intestinalis (PCI) that can occur after lupus-related bowel inflammation. While HBOT was part of a multi-faceted treatment approach that helped this patient, it is not a standard or Health Canada-approved treatment for PCI. Patients should discuss all treatment options with their healthcare providers.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. Pneumatosis cystoides intestinalis is not a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
As a single case report, this study's findings cannot be generalized to other patients, and it is difficult to determine the specific contribution of hyperbaric oxygen therapy among the many treatments used.